Skip to content

The study comparing two kashaya for relieving vulvar itching in females.

A comparative clinical study to evaluate the efficacy of Kanduhar mahakashaya and Sarivadi Kashaya in the management of Acharana yonivyapad W.S.R pruritis vulva - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111118
Enrollment
60
Registered
2026-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N908- Other specified noninflammatory disorders of vulva and perineum

Interventions

None listed

Sponsors

Dr Ritesh Chaturvedi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with lakshana of Acharana yonivyapad having Kandu , Srava, daurgandhya

Exclusion criteria

Exclusion criteria: patients after menopause, willing to conceive, patients of uterine prolapse and Ca cervix, on oral contraceptives or using intrauterine contraceptive devices, with Diabetes mellitus, tuberculosis, jaundice, severe HT, with extensive chronic cervicitis, fibroid and malignancy, VDRL,HIV, HBsAg positive patient, herpes, HPV positive patients, pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Reduction in severity of vulvar itching(kandu) assessed by grading scoreTimepoint: 30 days Trial drug is given for 30 days with anupana and follow up will be done after every 7 days

Secondary

MeasureTime frame
Improvement in Kandu, srava and daurgandhya after every 7 daysTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Mamata Kumari swain

Jeevan jyoti ayurvedic medical college and hospital Aligarh

swaindrmamata@gmail.com9348576189

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026